Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104056506 | 10405650 | 6 | F | 20140407 | 20160705 | 20140825 | 20160711 | EXP | CA-ROCHE-1453544 | ROCHE | 49.46 | YR | F | Y | 0.00000 | 20160712 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104056506 | 10405650 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0065E,S0066B,S0068D | 103976 | 150 | MG | |||||||
| 104056506 | 10405650 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0065E,S0066B,S0068D | 103976 | |||||||||
| 104056506 | 10405650 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0065E,S0066B,S0068D | 103976 | |||||||||
| 104056506 | 10405650 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0065E,S0066B,S0068D | 103976 | |||||||||
| 104056506 | 10405650 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0065E,S0066B,S0068D | 103976 | |||||||||
| 104056506 | 10405650 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0065E,S0066B,S0068D | 103976 | 150 | MG | |||||||
| 104056506 | 10405650 | 7 | C | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | SINCE 12 DAYS | 0 | TID | |||||||||
| 104056506 | 10405650 | 8 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | U | 0 | ||||||||||
| 104056506 | 10405650 | 9 | C | FLOVENT | FLUTICASONE PROPIONATE | 1 | Unknown | U | 0 | ||||||||||
| 104056506 | 10405650 | 10 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 104056506 | 10405650 | 1 | Asthma |
| 104056506 | 10405650 | 7 | Product used for unknown indication |
| 104056506 | 10405650 | 8 | Product used for unknown indication |
| 104056506 | 10405650 | 9 | Product used for unknown indication |
| 104056506 | 10405650 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 104056506 | 10405650 | OT |
| 104056506 | 10405650 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 104056506 | 10405650 | Blood pressure increased | |
| 104056506 | 10405650 | Bronchitis | |
| 104056506 | 10405650 | Cough | |
| 104056506 | 10405650 | Dysphonia | |
| 104056506 | 10405650 | Dyspnoea | |
| 104056506 | 10405650 | Pneumonia | |
| 104056506 | 10405650 | Pyelonephritis | |
| 104056506 | 10405650 | Sinusitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 104056506 | 10405650 | 1 | 20140401 | 0 | ||
| 104056506 | 10405650 | 2 | 20160315 | 0 | ||
| 104056506 | 10405650 | 3 | 20160412 | 0 | ||
| 104056506 | 10405650 | 4 | 20160510 | 0 | ||
| 104056506 | 10405650 | 5 | 20160608 | 0 | ||
| 104056506 | 10405650 | 6 | 20051216 | 0 |